SlideShare a Scribd company logo
Tillotts Pharma AG - Product Pipeline Review - 2015
Tillotts Pharma AG - Product Pipeline Review - 2015
Summary
Global Markets Directs, Tillotts Pharma AG - Product Pipeline Review - 2015, provides an overview of the Tillotts Pharma AGs pharmaceutical research and
development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Tillotts Pharma AGs, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest
updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of Tillotts Pharma AG including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Tillotts Pharma AGs human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Tillotts Pharma AGs pipeline products
Reasons to buy
- Evaluate Tillotts Pharma AGs strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Tillotts Pharma AG in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Tillotts Pharma AGs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those
areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Tillotts Pharma AG and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Tillotts Pharma AG
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of Tillotts Pharma AG and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 3
list Of Figures 3
tillotts Pharma Ag Snapshot 4
tillotts Pharma Ag Overview 4
key Information 4
key Facts 4
tillotts Pharma Ag - Research And Development Overview 5
key Therapeutic Areas 5
tillotts Pharma Ag - Pipeline Review 7
pipeline Products By Stage Of Development 7
pipeline Products - Monotherapy 8
tillotts Pharma Ag - Pipeline Products Glance 9
tillotts Pharma Ag - Late Stage Pipeline Products 9
Tillotts Pharma AG - Product Pipeline Review - 2015
pre-registration Products/combination Treatment Modalities 9
phase Iii Products/combination Treatment Modalities 10
tillotts Pharma Ag - Early Stage Pipeline Products 11
preclinical Products/combination Treatment Modalities 11
tillotts Pharma Ag - Drug Profiles 12
mesalamine Cr 12
product Description 12
mechanism Of Action 12
r&d Progress 12
mesalamine 13
product Description 13
mechanism Of Action 13
r&d Progress 13
tp-08 14
product Description 14
mechanism Of Action 14
r&d Progress 14
tp-10 15
product Description 15
mechanism Of Action 15
r&d Progress 15
tillotts Pharma Ag - Pipeline Analysis 16
tillotts Pharma Ag - Pipeline Products By Target 16
tillotts Pharma Ag - Pipeline Products By Route Of Administration 17
tillotts Pharma Ag - Pipeline Products By Molecule Type 18
tillotts Pharma Ag - Pipeline Products By Mechanism Of Action 19
tillotts Pharma Ag - Recent Pipeline Updates 20
tillotts Pharma Ag - Dormant Projects 21
tillotts Pharma Ag - Locations And Subsidiaries 22
head Office 22
other Locations & Subsidiaries 22
appendix 24
methodology 24
coverage 24
secondary Research 24
primary Research 24
expert Panel Validation 24
contact Us 24
disclaimer 25
list Of Tables
tillotts Pharma Ag, Key Information 4
tillotts Pharma Ag, Key Facts 4
tillotts Pharma Ag - Pipeline By Indication, 2015 6
tillotts Pharma Ag - Pipeline By Stage Of Development, 2015 7
tillotts Pharma Ag - Monotherapy Products In Pipeline, 2015 8
tillotts Pharma Ag - Pre-registration, 2015 9
tillotts Pharma Ag - Phase Iii, 2015 10
tillotts Pharma Ag - Preclinical, 2015 11
tillotts Pharma Ag - Pipeline By Target, 2015 16
tillotts Pharma Ag - Pipeline By Route Of Administration, 2015 17
tillotts Pharma Ag - Pipeline By Molecule Type, 2015 18
tillotts Pharma Ag - Pipeline Products By Mechanism Of Action, 2015 19
tillotts Pharma Ag - Recent Pipeline Updates, 2015 20
tillotts Pharma Ag - Dormant Developmental Projects,2015 21
tillotts Pharma Ag, Other Locations 22
tillotts Pharma Ag, Subsidiaries 22
list Of Figures
tillotts Pharma Ag - Pipeline By Top 10 Indication, 2015 6
tillotts Pharma Ag - Pipeline By Stage Of Development, 2015 7
tillotts Pharma Ag - Monotherapy Products In Pipeline, 2015 8
tillotts Pharma Ag - Pipeline By Top 10 Target, 2015 16
tillotts Pharma Ag - Pipeline By Top 10 Route Of Administration, 2015 17
tillotts Pharma Ag - Pipeline By Top 10 Molecule Type, 2015 18
tillotts Pharma Ag - Pipeline Products By Top 10 Mechanism Of Action, 2015 19
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
Tillotts Pharma AG - Product Pipeline Review - 2015
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Tillotts Pharma AG - Product Pipeline Review - 2015

More Related Content

What's hot

Nicotine addiction pipeline review, h1 2015
Nicotine addiction   pipeline review, h1 2015Nicotine addiction   pipeline review, h1 2015
Nicotine addiction pipeline review, h1 2015
Ambikabasa
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Rose088
 
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Ambikabasa
 
Non alcoholic steatohepatitis - pipeline review, h1 2014
Non alcoholic steatohepatitis - pipeline review, h1 2014Non alcoholic steatohepatitis - pipeline review, h1 2014
Non alcoholic steatohepatitis - pipeline review, h1 2014
Ambikabasa
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
Rose088
 
Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012
Rose088
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015
Ambikabasa
 
Food allergy pipeline review, h1 2015
Food allergy   pipeline review, h1 2015Food allergy   pipeline review, h1 2015
Food allergy pipeline review, h1 2015
Ambikabasa
 
Discount discount.....research aarkstore enterprise point of care diagnostic...
Discount discount.....research aarkstore enterprise  point of care diagnostic...Discount discount.....research aarkstore enterprise  point of care diagnostic...
Discount discount.....research aarkstore enterprise point of care diagnostic...Neel Terde
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012
Rose088
 
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...
Scott harm
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012
Rose088
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012
Rose088
 
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...ReportsnReports
 
Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012
Rose088
 
Penile cancer pipeline review, q3 2011
Penile cancer   pipeline review, q3 2011Penile cancer   pipeline review, q3 2011
Penile cancer pipeline review, q3 2011
linda3395
 
Integra gen s.a (alint) product pipeline analysis, 2014 update
Integra gen s.a (alint)   product pipeline analysis, 2014 updateIntegra gen s.a (alint)   product pipeline analysis, 2014 update
Integra gen s.a (alint) product pipeline analysis, 2014 update
Ambikabasa
 
Raynauds disease pipeline review, h1 2015
Raynauds disease   pipeline review, h1 2015Raynauds disease   pipeline review, h1 2015
Raynauds disease pipeline review, h1 2015
Ambikabasa
 
Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012
Rose088
 

What's hot (19)

Nicotine addiction pipeline review, h1 2015
Nicotine addiction   pipeline review, h1 2015Nicotine addiction   pipeline review, h1 2015
Nicotine addiction pipeline review, h1 2015
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
 
Non alcoholic steatohepatitis - pipeline review, h1 2014
Non alcoholic steatohepatitis - pipeline review, h1 2014Non alcoholic steatohepatitis - pipeline review, h1 2014
Non alcoholic steatohepatitis - pipeline review, h1 2014
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 
Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015
 
Food allergy pipeline review, h1 2015
Food allergy   pipeline review, h1 2015Food allergy   pipeline review, h1 2015
Food allergy pipeline review, h1 2015
 
Discount discount.....research aarkstore enterprise point of care diagnostic...
Discount discount.....research aarkstore enterprise  point of care diagnostic...Discount discount.....research aarkstore enterprise  point of care diagnostic...
Discount discount.....research aarkstore enterprise point of care diagnostic...
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012
 
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...
Actinic (Solar) Keratosis - Pipeline Review, H2 2016 - Market study and key c...
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012
 
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...
 
Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012
 
Penile cancer pipeline review, q3 2011
Penile cancer   pipeline review, q3 2011Penile cancer   pipeline review, q3 2011
Penile cancer pipeline review, q3 2011
 
Integra gen s.a (alint) product pipeline analysis, 2014 update
Integra gen s.a (alint)   product pipeline analysis, 2014 updateIntegra gen s.a (alint)   product pipeline analysis, 2014 update
Integra gen s.a (alint) product pipeline analysis, 2014 update
 
Raynauds disease pipeline review, h1 2015
Raynauds disease   pipeline review, h1 2015Raynauds disease   pipeline review, h1 2015
Raynauds disease pipeline review, h1 2015
 
Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012
 

Similar to Tillotts pharma ag product pipeline review - 2015

Arrhythmias pipeline review, h1 2015
Arrhythmias   pipeline review, h1 2015Arrhythmias   pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015
Ambikabasa
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
Rose088
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation   product pipeline review - 2015Genzyme corporation   product pipeline review - 2015
Genzyme corporation product pipeline review - 2015
Ambikabasa
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
Rose088
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012
Rose088
 
La bi tec gmbh - product pipeline analysis
La bi tec gmbh - product pipeline analysisLa bi tec gmbh - product pipeline analysis
La bi tec gmbh - product pipeline analysisAarkstore Enterprise
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
Rose088
 
Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012
Rose088
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012
Rose088
 
Alpha Glucosidase Inhibitors in-depth investigation of pipeline assets 2015
Alpha Glucosidase Inhibitors in-depth investigation of pipeline assets 2015Alpha Glucosidase Inhibitors in-depth investigation of pipeline assets 2015
Alpha Glucosidase Inhibitors in-depth investigation of pipeline assets 2015
Pete Jones
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Rose088
 
First light biosciences, inc. product pipeline analysis
First light biosciences, inc.   product pipeline analysisFirst light biosciences, inc.   product pipeline analysis
First light biosciences, inc. product pipeline analysisAarkstore Enterprise
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
Rose088
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
Rose088
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012
Rose088
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012
Rose088
 
PolyDADMAC are the main source of water purification and treatment process.
PolyDADMAC are the main source of water purification and treatment process.PolyDADMAC are the main source of water purification and treatment process.
PolyDADMAC are the main source of water purification and treatment process.
Sharath Chandra
 

Similar to Tillotts pharma ag product pipeline review - 2015 (18)

Arrhythmias pipeline review, h1 2015
Arrhythmias   pipeline review, h1 2015Arrhythmias   pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation   product pipeline review - 2015Genzyme corporation   product pipeline review - 2015
Genzyme corporation product pipeline review - 2015
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012
 
La bi tec gmbh - product pipeline analysis
La bi tec gmbh - product pipeline analysisLa bi tec gmbh - product pipeline analysis
La bi tec gmbh - product pipeline analysis
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
 
Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012
 
Alpha Glucosidase Inhibitors in-depth investigation of pipeline assets 2015
Alpha Glucosidase Inhibitors in-depth investigation of pipeline assets 2015Alpha Glucosidase Inhibitors in-depth investigation of pipeline assets 2015
Alpha Glucosidase Inhibitors in-depth investigation of pipeline assets 2015
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
First light biosciences, inc. product pipeline analysis
First light biosciences, inc.   product pipeline analysisFirst light biosciences, inc.   product pipeline analysis
First light biosciences, inc. product pipeline analysis
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012
 
PolyDADMAC are the main source of water purification and treatment process.
PolyDADMAC are the main source of water purification and treatment process.PolyDADMAC are the main source of water purification and treatment process.
PolyDADMAC are the main source of water purification and treatment process.
 

More from Ambikabasa

Uveitis global clinical trials review, h1, 2015
Uveitis global clinical trials review, h1, 2015Uveitis global clinical trials review, h1, 2015
Uveitis global clinical trials review, h1, 2015
Ambikabasa
 
Cleco corporation power plants and swot analysis, 2015 update
Cleco corporation   power plants and swot analysis, 2015 updateCleco corporation   power plants and swot analysis, 2015 update
Cleco corporation power plants and swot analysis, 2015 updateAmbikabasa
 
Philippines telecoms, mobile and broadband
Philippines   telecoms, mobile and broadbandPhilippines   telecoms, mobile and broadband
Philippines telecoms, mobile and broadband
Ambikabasa
 
Addiction pipeline review, h1 2015
Addiction   pipeline review, h1 2015Addiction   pipeline review, h1 2015
Addiction pipeline review, h1 2015
Ambikabasa
 
Ocular pain pipeline review, h1 2015
Ocular pain   pipeline review, h1 2015Ocular pain   pipeline review, h1 2015
Ocular pain pipeline review, h1 2015
Ambikabasa
 
Herpes zoster (shingles) pipeline review, h1 2015
Herpes zoster (shingles)   pipeline review, h1 2015Herpes zoster (shingles)   pipeline review, h1 2015
Herpes zoster (shingles) pipeline review, h1 2015
Ambikabasa
 
Cerebral infarction (brain infarction) pipeline review, h1 2015
Cerebral infarction (brain infarction)   pipeline review, h1 2015Cerebral infarction (brain infarction)   pipeline review, h1 2015
Cerebral infarction (brain infarction) pipeline review, h1 2015
Ambikabasa
 
H1 n1 infection pipeline review, h1 2015
H1 n1 infection   pipeline review, h1 2015H1 n1 infection   pipeline review, h1 2015
H1 n1 infection pipeline review, h1 2015
Ambikabasa
 
Uveal melanoma pipeline review, h1 2015
Uveal melanoma   pipeline review, h1 2015Uveal melanoma   pipeline review, h1 2015
Uveal melanoma pipeline review, h1 2015
Ambikabasa
 
Brain cancer pipeline review, h1 2015
Brain cancer   pipeline review, h1 2015Brain cancer   pipeline review, h1 2015
Brain cancer pipeline review, h1 2015
Ambikabasa
 
Diarrhea pipeline review, h1 2015
Diarrhea   pipeline review, h1 2015Diarrhea   pipeline review, h1 2015
Diarrhea pipeline review, h1 2015
Ambikabasa
 
Exercise trends - us - october 2014
Exercise trends  - us - october 2014Exercise trends  - us - october 2014
Exercise trends - us - october 2014
Ambikabasa
 
Travel and tourism in spain to 2018
Travel and tourism in spain to 2018Travel and tourism in spain to 2018
Travel and tourism in spain to 2018
Ambikabasa
 
Watches and jewellery retailing uk - september 2014
Watches and jewellery retailing   uk - september 2014Watches and jewellery retailing   uk - september 2014
Watches and jewellery retailing uk - september 2014
Ambikabasa
 
Sports participation uk - september 2014
Sports participation   uk - september 2014Sports participation   uk - september 2014
Sports participation uk - september 2014
Ambikabasa
 

More from Ambikabasa (15)

Uveitis global clinical trials review, h1, 2015
Uveitis global clinical trials review, h1, 2015Uveitis global clinical trials review, h1, 2015
Uveitis global clinical trials review, h1, 2015
 
Cleco corporation power plants and swot analysis, 2015 update
Cleco corporation   power plants and swot analysis, 2015 updateCleco corporation   power plants and swot analysis, 2015 update
Cleco corporation power plants and swot analysis, 2015 update
 
Philippines telecoms, mobile and broadband
Philippines   telecoms, mobile and broadbandPhilippines   telecoms, mobile and broadband
Philippines telecoms, mobile and broadband
 
Addiction pipeline review, h1 2015
Addiction   pipeline review, h1 2015Addiction   pipeline review, h1 2015
Addiction pipeline review, h1 2015
 
Ocular pain pipeline review, h1 2015
Ocular pain   pipeline review, h1 2015Ocular pain   pipeline review, h1 2015
Ocular pain pipeline review, h1 2015
 
Herpes zoster (shingles) pipeline review, h1 2015
Herpes zoster (shingles)   pipeline review, h1 2015Herpes zoster (shingles)   pipeline review, h1 2015
Herpes zoster (shingles) pipeline review, h1 2015
 
Cerebral infarction (brain infarction) pipeline review, h1 2015
Cerebral infarction (brain infarction)   pipeline review, h1 2015Cerebral infarction (brain infarction)   pipeline review, h1 2015
Cerebral infarction (brain infarction) pipeline review, h1 2015
 
H1 n1 infection pipeline review, h1 2015
H1 n1 infection   pipeline review, h1 2015H1 n1 infection   pipeline review, h1 2015
H1 n1 infection pipeline review, h1 2015
 
Uveal melanoma pipeline review, h1 2015
Uveal melanoma   pipeline review, h1 2015Uveal melanoma   pipeline review, h1 2015
Uveal melanoma pipeline review, h1 2015
 
Brain cancer pipeline review, h1 2015
Brain cancer   pipeline review, h1 2015Brain cancer   pipeline review, h1 2015
Brain cancer pipeline review, h1 2015
 
Diarrhea pipeline review, h1 2015
Diarrhea   pipeline review, h1 2015Diarrhea   pipeline review, h1 2015
Diarrhea pipeline review, h1 2015
 
Exercise trends - us - october 2014
Exercise trends  - us - october 2014Exercise trends  - us - october 2014
Exercise trends - us - october 2014
 
Travel and tourism in spain to 2018
Travel and tourism in spain to 2018Travel and tourism in spain to 2018
Travel and tourism in spain to 2018
 
Watches and jewellery retailing uk - september 2014
Watches and jewellery retailing   uk - september 2014Watches and jewellery retailing   uk - september 2014
Watches and jewellery retailing uk - september 2014
 
Sports participation uk - september 2014
Sports participation   uk - september 2014Sports participation   uk - september 2014
Sports participation uk - september 2014
 

Recently uploaded

ModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdfModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
fisherameliaisabella
 
Auditing study material for b.com final year students
Auditing study material for b.com final year  studentsAuditing study material for b.com final year  students
Auditing study material for b.com final year students
narasimhamurthyh4
 
ikea_woodgreen_petscharity_dog-alogue_digital.pdf
ikea_woodgreen_petscharity_dog-alogue_digital.pdfikea_woodgreen_petscharity_dog-alogue_digital.pdf
ikea_woodgreen_petscharity_dog-alogue_digital.pdf
agatadrynko
 
Enterprise Excellence is Inclusive Excellence.pdf
Enterprise Excellence is Inclusive Excellence.pdfEnterprise Excellence is Inclusive Excellence.pdf
Enterprise Excellence is Inclusive Excellence.pdf
KaiNexus
 
Kseniya Leshchenko: Shared development support service model as the way to ma...
Kseniya Leshchenko: Shared development support service model as the way to ma...Kseniya Leshchenko: Shared development support service model as the way to ma...
Kseniya Leshchenko: Shared development support service model as the way to ma...
Lviv Startup Club
 
Sustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & EconomySustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & Economy
Operational Excellence Consulting
 
Recruiting in the Digital Age: A Social Media Masterclass
Recruiting in the Digital Age: A Social Media MasterclassRecruiting in the Digital Age: A Social Media Masterclass
Recruiting in the Digital Age: A Social Media Masterclass
LuanWise
 
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdfMeas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
dylandmeas
 
Project File Report BBA 6th semester.pdf
Project File Report BBA 6th semester.pdfProject File Report BBA 6th semester.pdf
Project File Report BBA 6th semester.pdf
RajPriye
 
Improving profitability for small business
Improving profitability for small businessImproving profitability for small business
Improving profitability for small business
Ben Wann
 
Authentically Social by Corey Perlman - EO Puerto Rico
Authentically Social by Corey Perlman - EO Puerto RicoAuthentically Social by Corey Perlman - EO Puerto Rico
Authentically Social by Corey Perlman - EO Puerto Rico
Corey Perlman, Social Media Speaker and Consultant
 
The effects of customers service quality and online reviews on customer loyal...
The effects of customers service quality and online reviews on customer loyal...The effects of customers service quality and online reviews on customer loyal...
The effects of customers service quality and online reviews on customer loyal...
balatucanapplelovely
 
Business Valuation Principles for Entrepreneurs
Business Valuation Principles for EntrepreneursBusiness Valuation Principles for Entrepreneurs
Business Valuation Principles for Entrepreneurs
Ben Wann
 
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Lviv Startup Club
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
Cynthia Clay
 
20240425_ TJ Communications Credentials_compressed.pdf
20240425_ TJ Communications Credentials_compressed.pdf20240425_ TJ Communications Credentials_compressed.pdf
20240425_ TJ Communications Credentials_compressed.pdf
tjcomstrang
 
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challengesEvent Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Holger Mueller
 
Training my puppy and implementation in this story
Training my puppy and implementation in this storyTraining my puppy and implementation in this story
Training my puppy and implementation in this story
WilliamRodrigues148
 
Cree_Rey_BrandIdentityKit.PDF_PersonalBd
Cree_Rey_BrandIdentityKit.PDF_PersonalBdCree_Rey_BrandIdentityKit.PDF_PersonalBd
Cree_Rey_BrandIdentityKit.PDF_PersonalBd
creerey
 
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdfikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
agatadrynko
 

Recently uploaded (20)

ModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdfModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
 
Auditing study material for b.com final year students
Auditing study material for b.com final year  studentsAuditing study material for b.com final year  students
Auditing study material for b.com final year students
 
ikea_woodgreen_petscharity_dog-alogue_digital.pdf
ikea_woodgreen_petscharity_dog-alogue_digital.pdfikea_woodgreen_petscharity_dog-alogue_digital.pdf
ikea_woodgreen_petscharity_dog-alogue_digital.pdf
 
Enterprise Excellence is Inclusive Excellence.pdf
Enterprise Excellence is Inclusive Excellence.pdfEnterprise Excellence is Inclusive Excellence.pdf
Enterprise Excellence is Inclusive Excellence.pdf
 
Kseniya Leshchenko: Shared development support service model as the way to ma...
Kseniya Leshchenko: Shared development support service model as the way to ma...Kseniya Leshchenko: Shared development support service model as the way to ma...
Kseniya Leshchenko: Shared development support service model as the way to ma...
 
Sustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & EconomySustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & Economy
 
Recruiting in the Digital Age: A Social Media Masterclass
Recruiting in the Digital Age: A Social Media MasterclassRecruiting in the Digital Age: A Social Media Masterclass
Recruiting in the Digital Age: A Social Media Masterclass
 
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdfMeas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
 
Project File Report BBA 6th semester.pdf
Project File Report BBA 6th semester.pdfProject File Report BBA 6th semester.pdf
Project File Report BBA 6th semester.pdf
 
Improving profitability for small business
Improving profitability for small businessImproving profitability for small business
Improving profitability for small business
 
Authentically Social by Corey Perlman - EO Puerto Rico
Authentically Social by Corey Perlman - EO Puerto RicoAuthentically Social by Corey Perlman - EO Puerto Rico
Authentically Social by Corey Perlman - EO Puerto Rico
 
The effects of customers service quality and online reviews on customer loyal...
The effects of customers service quality and online reviews on customer loyal...The effects of customers service quality and online reviews on customer loyal...
The effects of customers service quality and online reviews on customer loyal...
 
Business Valuation Principles for Entrepreneurs
Business Valuation Principles for EntrepreneursBusiness Valuation Principles for Entrepreneurs
Business Valuation Principles for Entrepreneurs
 
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
 
20240425_ TJ Communications Credentials_compressed.pdf
20240425_ TJ Communications Credentials_compressed.pdf20240425_ TJ Communications Credentials_compressed.pdf
20240425_ TJ Communications Credentials_compressed.pdf
 
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challengesEvent Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
 
Training my puppy and implementation in this story
Training my puppy and implementation in this storyTraining my puppy and implementation in this story
Training my puppy and implementation in this story
 
Cree_Rey_BrandIdentityKit.PDF_PersonalBd
Cree_Rey_BrandIdentityKit.PDF_PersonalBdCree_Rey_BrandIdentityKit.PDF_PersonalBd
Cree_Rey_BrandIdentityKit.PDF_PersonalBd
 
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdfikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
 

Tillotts pharma ag product pipeline review - 2015

  • 1. Tillotts Pharma AG - Product Pipeline Review - 2015 Tillotts Pharma AG - Product Pipeline Review - 2015 Summary Global Markets Directs, Tillotts Pharma AG - Product Pipeline Review - 2015, provides an overview of the Tillotts Pharma AGs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Tillotts Pharma AGs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Tillotts Pharma AG including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Tillotts Pharma AGs human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Tillotts Pharma AGs pipeline products Reasons to buy - Evaluate Tillotts Pharma AGs strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Tillotts Pharma AG in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Tillotts Pharma AGs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Tillotts Pharma AG and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Tillotts Pharma AG - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Tillotts Pharma AG and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Table Of Contents table Of Contents 2 list Of Tables 3 list Of Figures 3 tillotts Pharma Ag Snapshot 4 tillotts Pharma Ag Overview 4 key Information 4 key Facts 4 tillotts Pharma Ag - Research And Development Overview 5 key Therapeutic Areas 5 tillotts Pharma Ag - Pipeline Review 7 pipeline Products By Stage Of Development 7 pipeline Products - Monotherapy 8 tillotts Pharma Ag - Pipeline Products Glance 9 tillotts Pharma Ag - Late Stage Pipeline Products 9 Tillotts Pharma AG - Product Pipeline Review - 2015
  • 2. pre-registration Products/combination Treatment Modalities 9 phase Iii Products/combination Treatment Modalities 10 tillotts Pharma Ag - Early Stage Pipeline Products 11 preclinical Products/combination Treatment Modalities 11 tillotts Pharma Ag - Drug Profiles 12 mesalamine Cr 12 product Description 12 mechanism Of Action 12 r&d Progress 12 mesalamine 13 product Description 13 mechanism Of Action 13 r&d Progress 13 tp-08 14 product Description 14 mechanism Of Action 14 r&d Progress 14 tp-10 15 product Description 15 mechanism Of Action 15 r&d Progress 15 tillotts Pharma Ag - Pipeline Analysis 16 tillotts Pharma Ag - Pipeline Products By Target 16 tillotts Pharma Ag - Pipeline Products By Route Of Administration 17 tillotts Pharma Ag - Pipeline Products By Molecule Type 18 tillotts Pharma Ag - Pipeline Products By Mechanism Of Action 19 tillotts Pharma Ag - Recent Pipeline Updates 20 tillotts Pharma Ag - Dormant Projects 21 tillotts Pharma Ag - Locations And Subsidiaries 22 head Office 22 other Locations & Subsidiaries 22 appendix 24 methodology 24 coverage 24 secondary Research 24 primary Research 24 expert Panel Validation 24 contact Us 24 disclaimer 25 list Of Tables tillotts Pharma Ag, Key Information 4 tillotts Pharma Ag, Key Facts 4 tillotts Pharma Ag - Pipeline By Indication, 2015 6 tillotts Pharma Ag - Pipeline By Stage Of Development, 2015 7 tillotts Pharma Ag - Monotherapy Products In Pipeline, 2015 8 tillotts Pharma Ag - Pre-registration, 2015 9 tillotts Pharma Ag - Phase Iii, 2015 10 tillotts Pharma Ag - Preclinical, 2015 11 tillotts Pharma Ag - Pipeline By Target, 2015 16 tillotts Pharma Ag - Pipeline By Route Of Administration, 2015 17 tillotts Pharma Ag - Pipeline By Molecule Type, 2015 18 tillotts Pharma Ag - Pipeline Products By Mechanism Of Action, 2015 19 tillotts Pharma Ag - Recent Pipeline Updates, 2015 20 tillotts Pharma Ag - Dormant Developmental Projects,2015 21 tillotts Pharma Ag, Other Locations 22 tillotts Pharma Ag, Subsidiaries 22 list Of Figures tillotts Pharma Ag - Pipeline By Top 10 Indication, 2015 6 tillotts Pharma Ag - Pipeline By Stage Of Development, 2015 7 tillotts Pharma Ag - Monotherapy Products In Pipeline, 2015 8 tillotts Pharma Ag - Pipeline By Top 10 Target, 2015 16 tillotts Pharma Ag - Pipeline By Top 10 Route Of Administration, 2015 17 tillotts Pharma Ag - Pipeline By Top 10 Molecule Type, 2015 18 tillotts Pharma Ag - Pipeline Products By Top 10 Mechanism Of Action, 2015 19 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your Tillotts Pharma AG - Product Pipeline Review - 2015
  • 3. research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: Sales Team, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Tillotts Pharma AG - Product Pipeline Review - 2015